The AERI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AERI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AERI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AERI Detailed Price Forecast - CNN Money||View AERI Detailed Summary - Google Finance|
|View AERI Detailed Summary - Yahoo! Finance||View AERI Stock Research & Analysis - Zacks.com|
|View AERI Trends & Analysis - Trade-Ideas||View AERI Major Holders - Barrons|
|View AERI Call Transcripts - NASDAQ||View AERI Breaking News & Analysis - Seeking Alpha|
|View AERI Annual Report - CompanySpotlight.com||View AERI OTC Short Report - OTCShortReport.com|
|View AERI Fundamentals - TradeKing||View AERI SEC Filings - Bar Chart|
|View Historical Prices for AERI - The WSJ||View Performance/Total Return for AERI - Morningstar|
|View the Analyst Estimates for AERI - MarketWatch||View the Earnings History for AERI - CNBC|
|View the AERI Earnings - StockMarketWatch||View AERI Buy or Sell Recommendations - MacroAxis|
|View the AERI Bullish Patterns - American Bulls||View AERI Short Pain Metrics - ShortPainBot.com|
|View AERI Stock Mentions - StockTwits||View AERI Stock Mentions - PennyStockTweets|
|View AERI Stock Mentions - Twitter||View AERI Investment Forum News - Investor Hub|
|View AERI Stock Mentions - Yahoo! Message Board||View AERI Stock Mentions - Seeking Alpha|
|View Insider Transactions for AERI - SECform4.com||View Insider Transactions for AERI - Insider Cow|
|View AERI Major Holdings Summary - CNBC||View Insider Disclosure for AERI - OTC Markets|
|View Insider Transactions for AERI - Yahoo! Finance||View Institutional Holdings for AERI - NASDAQ|
|View AERI Stock Insight & Charts - FinViz.com||View AERI Investment Charts - StockCharts.com|
|View AERI Stock Overview & Charts - BarChart||View AERI User Generated Charts - Trading View|
See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc.
Posted on Saturday September 15, 2018
Short interest is moderate for AERI with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
Aerie Pharmaceuticals to Present at Ophthalmology Futures Forums in Vienna, Austria
Posted on Thursday September 13, 2018
Aerie Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced that Richard Rubino, Chief Financial Officer, will present at the Ophthalmology Futures European Forum held prior to the 36th Congress ...
Aerie Pharmaceuticals Appoints David W. Gryska to the Company’s Board of Directors
Posted on Wednesday September 12, 2018
Aerie Pharmaceuticals, Inc. (AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced that David W. Gryska has been appointed to the Company’s Board of Directors and will also be a member of the Audit Committee of the Board. Mr. Gryska recently announced his planned retirement at the end of 2018 as the Chief Financial Officer and Executive Vice President of Incyte Corp., and is currently on the boards of Seattle Genetics, Inc. and PDL BioPharma, Inc. Previously, he held the position of President, CEO, COO and Director at Myrexis, Inc., Chief Financial Officer and Senior Vice President at Celgene Corp., and Chief Financial Officer and Senior Vice President at Scios, Inc. Mr. Gryska has spent over 20 years as a senior executive at life science and biotechnology companies with extensive experience relating to financings, acquisitions, global expansion and strategic transactions.
Today's Research Reports on Trending Tickers: Momenta Pharmaceuticals and Aerie Pharmaceuticals
Posted on Wednesday September 12, 2018
The Dow Jones Industrial Average climbed 0.44 percent to close at 25,971.06, while the S&P 500 Index increased 0.37 percent to close at 2,887.89. The Nasdaq Composite Index gained 0.61 percent to close at 7,972.47.